← Back to Search

Cancer Vaccine

Proscavax for Prostate Cancer

Phase 2
Waitlist Available
Led By Rupal S Bhatt, MD, PhD
Research Sponsored by OncBioMune Pharmaceuticals
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at pre-study, and then every 3 months till 2 years, starting at week 7 for both arms
Awards & highlights

Study Summary

Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at pre-study, and then every 3 months till 2 years, starting at week 7 for both arms
This trial's timeline: 3 weeks for screening, Varies for treatment, and at pre-study, and then every 3 months till 2 years, starting at week 7 for both arms for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Prostate cancer progression measured by PSA test
Prostate cancer progression measured by digital rectal examination (DRE)
Prostate cancer progression measured by prostate Biopsy
Secondary outcome measures
Assessment of Adverse Events
PSA doubling time

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arm 1 - Proscavax vaccine treatmentExperimental Treatment1 Intervention
In this arm, during the first 4 months of induction treatment, 6 doses of the Proscavax vaccine will be administered intradermally at weeks 1, 2, 3, 7, 11, and 15, followed by maintenance booster injections once every month which will alternate between low dose IL-2 alone (at weeks 19, 27 and 35) and Proscavax vaccine (at weeks 23, 31, 39) for 6 months.
Group II: Arm 2 - Active SurveillanceActive Control1 Intervention
In this arm, patients will undergo active surveillance and will not receive any Proscavax vaccine treatment.

Find a Location

Who is running the clinical trial?

OncBioMune PharmaceuticalsLead Sponsor
1 Previous Clinical Trials
48 Total Patients Enrolled
1 Trials studying Prostate Cancer
48 Patients Enrolled for Prostate Cancer
Rupal S Bhatt, MD, PhDPrincipal InvestigatorHarvard Medical Faculty Physicians Practice

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
2019. "Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03579654.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top